Organon (MEX:OGN) Institutional Ownership: 44.17% (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OGN Organon & Co MEX:OGN
58 GF Score
Price MXN229.00
GF Value MXN246.64
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Organon Institutional Ownership?

Organon MEX:OGN 58 Institutional Ownership is 44.17% as of Jul. 14, 2026. GuruFocus rates MEX:OGN with a GF Score™ of 58/100 and a GF Value™ of MXN246.64 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Organon's institutional ownership is 44.17%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Organon's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Organon's Float Percentage Of Total Shares Outstanding is 87.97%.

Organon Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Organon's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organon Institutional Ownership Chart

Organon Historical Data

The historical data trend for Organon can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 51.09 49.87 49.29 48.87 47.55 48.71 44.36 44.42 44.71 44.17
MEX:OGN
58GF Score
Organon & Co MEX:OGN
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organon Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 44.17% mean?
Organon (MEX:OGN) has a Institutional Ownership of 44.17% as of Jul. 14, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Organon and its competitors.
Is Organon's Institutional Ownership too high?
Organon's current Institutional Ownership is 44.17%. Overall, Organon has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Organon's Institutional Ownership compare to AMRN and SCLX?
Organon's Institutional Ownership of 44.17% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Organon and its competitors. Organon's current Institutional Ownership is 44.17%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organon stock overvalued right now?
Based on GuruFocus' analysis, Organon (MEX:OGN) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN246.64, compared to a current price of MXN229.00 — trading 7.2% below its estimated fair value. The current Institutional Ownership is 44.17%. Organon's overall GF Score™ is 58/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Organon (MEX:OGN), the current Institutional Ownership is 44.17% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organon (MEX:OGN) Overvalued in 2026?

Based on GuruFocus' analysis, Organon stock appears to be undervalued. The current stock price of MXN229.00 is trading 7.2% below its estimated GF Value™ of MXN246.64. GuruFocus considers Organon to be Modestly Undervalued.

Key valuation signals for MEX:OGN:

  • Institutional Ownership: 44.17%
  • GF Value™: MXN246.64 vs. price of MXN229.00 (7.2% below fair value)
  • GF Score™: 58/100 with 10 warning signs

No single metric tells the full story. See the MEX:OGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Organon Business Description

Address 30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
58GF Score

Get the complete analysis for MEX:OGN

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN229.00
Price
MXN246.64
GF Value